Author:
Wauters Lucas,Ceulemans Matthias,Schol Jolien,Farré Ricard,Tack Jan,Vanuytsel Tim
Abstract
Patients with functional dyspepsia (FD) complain of epigastric symptoms with no identifiable cause. Increased intestinal permeability has been described in these patients, especially in the proximal small bowel or duodenum, and was associated with mucosal immune activation and symptoms. In this review, we discuss duodenal barrier function, including techniques currently applied in FD research. We summarize the available data on duodenal permeability in FD and factors associated to increased permeability, including mucosal eosinophils, mast cells, luminal and systemic factors. While the increased influx of antigens into the duodenal mucosa could result in local immune activation, clinical evidence for a causal role of permeability is lacking in the absence of specific barrier-protective treatments. As both existing and novel treatments, including proton pump inhibitors (PPI) and pre- or probiotics may impact duodenal barrier function, it is important to recognize and study these alterations to improve the knowledge and management of FD.
Reference90 articles.
1. Animal models for functional gastrointestinal disorders.;Accarie;Front. Psychiatry,2020
2. Local immune response to food antigens drives meal-induced abdominal pain.;Aguilera-Lizarraga;Nature,2021
3. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study.;Aziz;Lancet. Gastroenterol. Hepatol.,2018
4. Vasoactive intestinal polypeptide and mast cells regulate increased passage of colonic bacteria in patients with irritable bowel syndrome.;Bednarska;Gastroenterology,2017
5. Relationship between bile salts, bacterial translocation, and duodenal mucosal integrity in functional dyspepsia.;Beeckmans;Neurogastroenterol Motil.,2020
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献